樂心醫療(300562.SZ):通過對核心傳感器的延伸應用研究,公司成功進入智能貨架領域
格隆匯8月23日丨有投資者向樂心醫療(300562.SZ)提問,“請問貴公司是否有自研傳感器,如果有,相應傳感器具體都有哪些應用?”
樂心醫療回覆稱,公司長期堅持以研發創新為主導,在核心部件(智能傳感器、氣泵、傳感器光路設計等)和算法上實現自研自產,中山市創源傳感器有限公司系公司全資子公司,主要負責智能傳感器等核心部件的研發、生產與銷售。公司主要產品品類中家用體脂秤、體重秤、廚房秤等衡器類產品均使用公司自主研發設計生產的傳感器。通過對核心傳感器的延伸應用研究,公司成功進入智能貨架領域,產品主要應用於智能無人零售、智能辦公等場景。未來,公司會持續保持在遠程醫療、家用醫療、基層醫療、慢病管理等領域的研發創新,進一步夯實公司競爭壁壘。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.